macrocyclic cyclophilin inhibitors (Cypralis)

N/A

Report date: 2025/01/26 18:50:54
NME

Base Information

Drug Namemacrocyclic cyclophilin inhibitors (Cypralis)
Drug Alias Namecyprolides (Cypralis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclophilin D inhibitors
TargetsCyclophilin D
Therapy Area/IndicationsNerve DegenerationHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCypralis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCypralis Ltd
Inactive CompaniesN/A
Active IndicationsNerve DegenerationHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A